We have used transpositional mutagenesis of a proline auxotroph (PAO951) to isolate an ornithine utilization (oru) mutant of Pseudomonas aeruginosa (PAO951-4) that was unable to use ornithine efficiently as the sole carbon and nitrogen source. DNA sequence analysis of the inactivated locus confirmed that the transposon had inserted into a locus whose product demonstrated significant primary sequence homology to members of the AraC family of transcriptional activators. DNA mobility shift assays affirmed this potential regulatory function and indicated that the inactivated gene encodes a transcriptional regulator, which has been designated OruR. In trying to define the ornithine utilization phenotype further, a similar inactivation was engineered in the wild-type strain, PAO1. The resulting isolate (PAO1R4) was totally unable to use ornithine as the sole carbon source. Despite the intensified phenotype, this isolate failed to demonstrate significant changes in any of the catabolic or anabolic enzymes that are known to be subject to regulation by the presence of either ornithine or arginine. It did, however, show modified levels of an enzyme, ornithine acetyltransferase (OAcT), that was previously thought to have merely an anaplerotic activity. Definition of this oruR locus and its effects upon OAcT activity provide evidence that control of ornithine levels in P. aeruginosa may have a significant impact upon how the cell is able to monitor and regulate the use of arginine and glutamate as sources of either carbon or nitrogen.
The versatility with which Pseudomonas aeruginosa PAO1 is able to utilize a wide variety of compounds as sole carbon and nitrogen sources is manifest in the complex and intricate nature of its arginine metabolism (4, 11) (Fig. 1) . Unlike the situation in enteric bacteria, where the entire arginine biosynthetic regulon is controlled by a single arginine repressor (9) , only two of the genes that specifically relate to arginine biosynthesis in P. aeruginosa, namely, argF and argD, have been shown to be regulated by arginine (4, 11, 27) . Significantly, perhaps, both these genes encode enzymes (anabolic ornithine transcarbamylase [aOTCase] [argF] and ornithine aminotransferase [OAT] [argD]) that catalyze important branch points in arginine metabolism (Fig. 1) . In so doing, they ultimately decide the fate of the key biosynthetic precursor, ornithine.
The first of these enzymes, aOTCase (argF), catalyzes the sixth step in arginine biosynthesis, converting ornithine into citrulline. Expression of this enzyme can be repressed up to 18-fold by the presence of exogenous arginine (13, 20, 40) . The second enzyme, succinylornithineaminotransferase (SOAT; encoded by argD), is able to catalyze three distinct transaminase reactions within the arginine metabolic network: (i) the aforementioned OAT reaction, (ii) the biosynthesis of acetylornithine (ACOAT), and (iii) the transamination of succinylornithine (SOAT), from which the enzyme gets its name (Fig.  1) . The relative importance of this enzyme's contrasting catabolic and anabolic activities (SOAT/OAT versus ACOAT) heavily favors catabolism, giving ACOAT the curious distinction of being the only anabolic enzyme within the arginine biosynthetic pathway whose expression is actually induced by the end product, arginine (11) .
Two other enzymes have also been implicated in the metabolism of ornithine. The first is ornithine succinyltransferase (OST; encoded by aruA), which is a bifunctional enzyme that is also able to preferentially succinylate arginine (AST) (36) . In P. aeruginosa, this enzyme is involved in the catabolism of both ornithine and arginine through the arginine succinyl pathway (4, 11, 36) (Fig. 1) . The second enzyme is ornithine acetyltransferase (OAcT; encoded by argJ) (Fig. 1) , which is thought to be involved merely in the regeneration of the acetyl group that is used up in the first committed step of the de novo pathway (4, 21) (Fig. 1 ). This ability to recycle the acetyl group is found in a number of organisms other than the enteric bacteria and is thought to define a more "evolved" form of arginine metabolism, which apparently comes at the expense of a more elaborate regulatory scheme (3, 4, 29) .
It is the regulation of all four of these enzymes that is of interest to this report, since we attempted to investigate more thoroughly the role of ornithine in the overall regulatory scheme of arginine metabolism. Initially, particular attention was given to the expression of the multifunctional SOAT and its OAT activity (Fig. 1) . It was this activity that was used to great effect by Voellmy and Leisinger in obtaining a number of arginine-regulatory mutants (40) after more conventional attempts at obtaining similar mutants had failed (13) . Voellmy and Leisinger used a conditional proline auxotroph (PAO951), which lacked a functional L-glutamate phosphotransferase (encoded by proA), reasoning that this block in de novo proline biosynthesis could be circumvented only by an organism that could take glutamate up to ornithine and from there across to proline through a markedly enhanced activity of the OAT (Fig.  1) . Since the expression of this enzyme is normally regulated by arginine, they proposed that they could select for regulatory mutants by selecting for its overexpression. They further believed that the presence of citrate, which normally catabolite represses argD expression (40) , would exaggerate any requirement for the overexpression of OAT. This approach was successfully used to select for a number of "citrate resistant" (CIT r ) derivative mutants of the proline auxotroph, PAO951, with ethyl methanesulfonate (EMS) as the mutagen of choice.
Unlike the parent strain, PAO951, these phenotypic suppressor mutants were able to grow on ornithine and citrate as their sole nitrogen and carbon sources, evidently at the expense of any regulatory constraint that would normally be imposed upon the aminotransferase (SOAT/OAT). One of these CIT r derivatives (PAO959) was isolated and found to exhibit altered arginine metabolic regulation, whereby aOTCase was shown to be permanently repressed while SOAT (OAT) was maintained at a constitutively high level (40) .
More recently, Itoh and Matsumoto (14) obtained additional regulatory mutants (again through EMS mutagenesis), this time using selection for chromosomally encoded mutations that promoted streptomycin resistance from a plasmid-borne argF::strA gene fusion. In the resulting mutant isolates, aOTCase was constitutively expressed at high levels while SOAT was no longer inducible by arginine. Although opposite in nature, these more recent results confirmed that, whatever the mechanism(s) for arginine control in P. aeruginosa, expression of the two enzymes aOTCase and SOAT (OAT) seems to remain inexorably linked in an inverse relationship.
Despite the elegant design of both these mutagenic approaches, the precise nature and genetic location of the different regulatory genes that control the metabolism of ornithine and arginine in P. aeruginosa are still unclear. Consequently, the genetic characterization of any such regulatory mutation affecting arginine or ornithine metabolism remains intriguing. We report here the isolation and initial characterization of one such regulatory mutant, initially obtained by coupling transpositional mutagenesis with the strong selective pressure of citrate resistance upon the conditional proline auxotroph PAO951. In addition, we summarize the cloning and DNA sequence of this inactivated locus. We also report some preliminary characterization of its potential role in regulating the utilization of ornithine in the cell and, by extension, its role in the metabolism of arginine.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . P. aeruginosa PAO951 and PAO959 and Escherichia coli ED8654 (bearing the suicide vector pME9) were gifts from D. Haas. Plasmid pGM⍀1 was a gift from R. Schweizer.
Media and growth conditions. Unless stated otherwise, all bacterial cells were grown aerobically with continuous shaking at 37°C in either Luria-Bertani (LB) enriched medium (26) or nitrogen-free minimal medium P (MMP) that had been supplemented with appropriate carbon and nitrogen sources, each at a final concentration of 20 mM (21) . For E. coli, ampicillin was used at 75 g/ml when used alone and at 30 g/ml when used in combination with trimethoprim (500 g/ml) and gentamicin was used at 15 g/ml. For P. aeruginosa, carbenicillin was used at 500 g/ml and tetracycline was used at 125 g/ml. When required, gentamicin was added to the growth medium to a final concentration of 250 g/ml and streptomycin was used at 500 g/ml. When either kanamycin or trimethoprim was used to verify the presence of the transposon Tn5-751, they were used at 300 and 500 g/ml, respectively.
For enzyme analysis, the various strains of P. aeruginosa were grown to an optical density at 600 nm of 0.6 in 50-ml cultures of MMP, fortified with different specific carbon and nitrogen sources. Owing to the high phenotypic reversion rate of some of the mutant strains of P. aeruginosa, care was taken to verify that the phenotype of the cells under assay was the same as that determined following mutagenesis. Therefore, prior to incubation in defined medium, all the cells were initially selected for their ability to grow in MMP containing ornithine, citrate, and kanamycin, washed, and preincubated in 5-ml cultures of the selective medium in which they were to be assayed.
Isolation of Tn5-751 insertional inactivation mutants of PAO951. Following incubation in LB medium containing kanamycin and tetracycline, E. coli ED8654 cells (harboring the temperature-sensitive suicide plasmid pME9 [28] ) were mixed 1:1 with P. aeruginosa PAO951 on LB agar and allowed to incubate for 4 h at 30°C. After this time, the cells were washed from the LB agar with 1 ml of 0.9% (wt/vol) NaCl and plated in 100-to 200-l aliquots onto selective MMP supplemented with proline, arginine, ammonium sulfate (15 mM), citrate, kanamycin, and trimethoprim. This minimal medium was chosen to avoid direct selection against arginine metabolic mutants while still being able to counterselect for the methionine auxotrophic parental E. coli strain, ED8654. The FIG. 1. Simplified schematic of the arginine metabolic pathways in P. aeruginosa. The arginine biosynthetic pathway is shown by the darkly shaded arrows, the arginine succinyltransferase pathway is shown by the thin white arrows, the proline anabolic pathway is shown by the black arrows, and the proline degradation pathway is shown by the lightly shaded arrows. Reactions that pertain specifically to this work are depicted by larger arrows with shadows and are either named or numbered 1 through 3: SOAT, ACOAT, and OAT are derived from the trifunctional product of the argD/aruC locus; aOTCase is the argF product; AST is the bifunctional product of aruA (which also exhibits OST activity); OAcT is encoded by argJ; 1, NADP-dependent anabolic glutamate dehydrogenase (NADP-GDH; encoded by gdhA); 2, NAD-dependent catabolic glutamate dehydrogenase (NAD-GDH); 3, catabolic cOTCase (encoded by arcB). The proline block within proA, which is present in PAO951, is denoted by a cross through the appropriate arrow, and the inactivated gene is designated "proA (PAO951)". Additional names and arginine metabolic pathways (11) (28) . Consequently, this vector provided an appropriate means for the introduction of the transposon Tn5-751 into P. aeruginosa PAO951. Recipient P. aeruginosa colonies, obtained by growth on the selective medium, were picked to a master plate of the same medium and incubated at 37°C before being isolated twice by incubation at 42°C on LB agar supplemented with kanamycin and trimethoprim. The resulting colonies were screened for their acquired ability to grow on MMP augmented with ornithine and citrate, as well as for their inability to grow on medium containing carbenicillin and tetracycline (antibiotic resistance markers specific to the pME9 vector). Such Tn5-751-induced citrate-resistant mutants that had retained the proline block in proA were investigated further. Several matings were undertaken in parallel to reduce the risk of isolating siblings. Purification and in vitro manipulation of DNA. Genomic and plasmid DNA was isolated as described by Sambrook et al. (30) . Restriction endonuclease digestion and ligation of DNA were performed as specified by the manufacturers. Digested chromosomal DNA was cloned into E. coli expression vectors (pUC18 or pUC19) (39) with ϳ10 g of chromosomal DNA and ϳ1 g of plasmid DNA. Vector DNA was digested and dephosphorylated by the method defined by Sambrook et al. (30) . E. coli was transformed with calcium chloridetreated cells (30) .
DNA sequence analysis. The DNA sequence was determined by a modification of the dideoxy chain termination method of Sanger et al. (31) with enzymes and reagents supplied by United States Biochemicals Corp. (except for the 35 S-dATP radioactive label, which was purchased from Amersham, Inc.). DNA sequence analysis of the cloned region (along with the localization of Tn5-751 insertions within the inactivated gene) was determined on both strands with a range of double-stranded plasmid subclones. Whenever convenient sites for restriction were not readily available, oligonucleotide primers, typically 18 to 23 bp long, were used to extend and confirm the DNA sequence. Interpretation of the DNA sequence was assisted by the MacVector computer analysis program, version 4.5, from Kodak, and the BLAST protein analysis program that is readily available from the National Center for Biotechnology Information on the Internet.
Southern hybridization and DNA manipulations. Following complete digestion with appropriate restriction enzymes and agarose gel electrophoresis, genomic and plasmid DNA was transferred to a nylon membrane, hybridized to assorted digoxigenin-labeled probes, and detected as described by Kwon et al. (19) . The inactivated gene was cloned within the CIT r mutant, PAO951-4, by a modification of the procedure described by Rella et al. (28) , wherein SalIdigested fragments of chromosomal DNA were cloned into pUC18 and transformed into E. coli DH5␣. The absence of ␤-galactosidase activity in these clonal isolates was determined by monitoring the presence of white colonies on a YT plate to which 2% (wt/vol) 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) had been added. These clones were then partially sequenced with a Tn5-specific primer (12), which was able to provide the sequence of chromosomal DNA flanking the site of the Tn5-751 insertion. Using a fragment of cloned DNA as a probe, colony hybridizations were conducted with a P. aeruginosa cosmid library (19) . Cosmid DNA was obtained from the positive colonies and subjected to restriction endonuclease digestion and subsequent Southern hybridization in a manner similar to that described above.
Isolation of a gentamicin cassette-induced mutant derivative of PAO1. A modification of the procedure described in reference 35 was used to introduce a SmaI fragment of pGM⍀1 (containing a gentamicin resistance structural gene) into a ScaI site within an intact, wild-type clone of the chromosomal gene that had previously been shown to have been inactivated by Tn5-751 (pMH4.1) ( Table 1 ; Fig. 2 ). The resulting construct was digested with SalI, yielding a 4.1-kbp fragment that encompassed both the inactivated gene and the gentamicin cassette (Fig. 2) . This fragment was cloned into pRTP1 (pMHG2), which was subsequently conjugated into streptomycin-resistant PAO1 cells via an E. coli SM10 (streptomycin-sensitive) intermediate. The resulting recombinants were selected through antibiotic selection and then screened for the presence of the gentamicin cassette by Southern hybridization of their chromosomal DNA with appropriate DNA probes.
Enzyme assays. Upon reaching an optical density at 600 nm of 0.6, cells that had been grown in 50-ml cultures of MMP (fortified with appropriate carbon and nitrogen sources) were harvested by centrifugation, washed, and resuspended in 5 ml of breaking buffer (50 mM KH 2 PO 4 , 0.5 mM EDTA [pH 7.5]). Cell extracts were obtained by 15 bursts of sonication with a Fisher Scientific no. 50 sonic dismembrator at an output setting of 15%. Cell debris was removed by centrifugation at 10,000 ϫ g for 10 min in a microcentrifuge. SOAT was assayed by the method of Voellmy and Leisinger (40) ; aOTCase and cOTCase were assayed by a method defined by Haas et al. (10) ; AST was assayed by previously defined procedures (38) ; OAcT was assayed by a method defined by Isaac and Holloway (5, 13); and both the catabolic and anabolic glutamate dehydrogenases were assayed by the method of Joannou and Brown (17) . The protein concentration was determined by the method of Bradford (1) with bovine serum albumin as the standard. DNA mobility shift assays. Mobility shift assays were used to assess the binding of the cloned OruR protein to its own promoter. By using a previously described protocol (23), the 176-bp fragment of promoter DNA was amplified from the cloned DNA within PAO1R4 by using primers shown in Fig. 3 . The purified PCR fragment was used for mobility shift assays by a previously published protocol (23) but with a modification described by Carey (2) to accommodate the low pI of the protein; this allowed a greater resolution of the gel shift assay.
Chemicals and reagents. All the restriction enzymes used in this study were obtained from commercial sources, as were the chemicals and enzymes used in the manipulation of DNA. All the other chemicals and reagents were of reagent grade or of the highest-quality grade available.
Nucleotide sequence accession number. The nucleotide sequence and deduced protein sequence reported here were submitted to GenBank and assigned accession no. U73506.
RESULTS
Isolation of Tn5-751-induced CIT r mutants of PAO951. Transpositional mutagenesis of PAO951 yielded approximately 5,500 mutant isolates, of which 6 were found to have acquired the ability to grow on minimal medium supplemented with ornithine and citrate. Because altered levels of SOAT were considered necessary to overcome the pro-137 proline block within PAO951 (40) , all six of these CIT r mutants, which had been grown up in ornithine and citrate minimal medium, were assayed for this enzyme. While all six isolates exhibited high levels of SOAT, PAO951-4 consistently gave exceptionally high levels of this enzyme and was investigated further.
Southern hybridization experiments with a 320-bp HindIIIBglII fragment from Tn5-751 confirmed that this mutant isolate was the result of a single transpositional insertion (data not shown). The PAO951-4 isolate had growth patterns similar to those of its parental strain, PAO951, except for its newly acquired ability to grow in ornithine and citrate minimal medium and a pronounced deficiency in its ability to use ornithine as the sole carbon and nitrogen source. Cloning of the inactivated gene locus, cosmid isolation, and specific subclones. By exploiting SalI restriction sites within Tn5-751 that separate the two resistance gene markers, both arms of the transposon (together with neighboring chromosomal DNA) were independently cloned into pUC18. The size of each of these fragments corresponded precisely to that predicted by Southern analysis, which had previously been undertaken for each of the different DNA isolates (data not shown). DNA probes were generated for each of the flanking chromosomal DNA regions, and these probes were used to probe a P. aeruginosa PAO1 cosmid library (19) . Cosmid DNA that hybridized to the probe was subcloned and mapped, yielding the restriction digest map depicted in Fig. 2 . Subsequent DNA sequence analysis of this region confirmed the presence of a deduced open reading frame (ORF) encoding a product of 339 amino acid residues (Fig. 3) . The reading frame and the first eight amino acids (including the N-terminal methionine) were confirmed by N-terminal sequence analysis of a purified protein fragment derived from of the cloned gene that had been overexpressed in E. coli. Comparison of the deduced amino acid sequence of the ORF with sequences in the GenBank database showed that the protein possesses a distinct primary sequence similarity to UreR and AraC (19 and 22% identity, respectively). This homology was essentially confined to the C-terminal sequence of each locus, especially in the amino acids that characterize the C-terminal DNA binding region for the AraC family of DNA binding proteins (6) (Fig. 4) .
Enzyme analyses. The enzyme activities of the three enzymes that are critically responsible for ornithine and arginine metabolism, i.e., SOAT/ACOAT/OAT, aOTCase, and AST/ OST, were assayed in each of following four different strains of P. aeruginosa: the wild type (PAO1), the conditional proline auxotroph (PAO951 [40] ), an original CIT r isolate derived from PAO951 (PAO959 [40] ) and the Tn5-751 CIT r derivative (PAO951-4 [this work]). The results of these assays are given in Table 2 . The SOAT and aOTCase enzyme activities from PAO1, PAO951, and PAO959 are in excellent agreement with their previously defined activities (40) , with one notable exception. In our hands, the aOTCase level for PAO959 (when grown in MMP supplemented with ornithine and citrate) appears to be repressed, which is the inverse of the previous result (40) . Such findings were reproducible, however, and are entirely consistent with the inverse association of aOTCase and SOAT that is found in PAO959 under all other growth conditions. The results for the activity of the AST enzyme are also consistent with the strictly catabolic nature of this enzyme, since the activity levels of AST were induced for both PAO1 and PAO951 when the cells were grown in the presence of either arginine or ornithine.
What is also apparent from the levels of SOAT, aOTCase, and AST in the mutant isolates (Table 2) is that these enzymes were no longer subject to the same arginine specific controls as either the wild type (PAO1) or the conditional proline auxotroph (PAO951). In a manner similar to the PAO959 isolate, Table 1 ) that were isolated throughout the course of the investigation. In addition, the relative locations of primers, which were used to clone and amplify the native oruR gene from the chromosome of PAO1, are depicted as arrows. The direction of transcription from plasmid-borne promoters is also shown by a larger arrow.
FIG. 3.
Nucleotide sequence of the coding strands for the oruR region from P. aeruginosa PAO1. The deduced amino acid sequence encoded by the ORF is shown below the corresponding DNA sequence. The annotation Tn5-751 (PAO951-4) designates the site where insertion of the transposon has been documented within the oruR mutant gene from PAO951-4. Likewise, the annotation Gm r ⍀ (PAO1R4) designates the site where the gentamicin resistance cassette was inserted with the ScaI restriction enzyme (underlined). Also underlined are additional restriction enzyme sites that were manufactured within the 5Ј termini of synthetic primers to facilitate the cloning of a PCR product which encompasses the purported oruR promoter region. Lowercase letters denote bases within these primers that are not complementary or equivalent to the defined sequence. Dots denote bases that are complementary. Double underlining denotes the presumed Shine-Dalgarno sequence for the oruR structural gene. the transpositionally induced CIT r mutant, PAO951-4, exhibits constitutively high levels of SOAT and correspondingly repressed levels of aOTCase. Curiously, in both PAO951-4 and PAO959, the activity of the catabolic AST/OST was also severely depressed under all growth conditions tested.
Inactivation and enzymatic characterization of an ORF null mutation in PAO1. To confirm and characterize the phenotypic properties of the transpositionally inactivated locus (unhindered by any complexities resulting from proline requirements), the region of DNA encompassing the ORF was cloned into pUC18, resulting in pMH4.1 (Table 1 ; Fig. 2) . The gene was then inactivated by using a Gm r cassette in the structural gene, and the inactivated locus was subcloned into a suicide vector. The resulting construct (pMHG2 [Table 1 ; Fig. 2] ) was transformed into PAO1 and was able to inactivate the wildtype chromosomal gene through a double recombinational event that could be monitored by selection for growth on appropriate antibiotic-containing media. The precise location of the Gm r cassette was subsequently confirmed by Southern hybridization with a 1.5-kbp EcoRI-SalI DNA fragment (Fig.  2 ) from pMH4.1 as the probe (data not shown). This recombinant strain (PAO1R4) was analyzed for growth on selective media and for the activity of a number of the enzymes within the arginine metabolic pathways. As expected from previous growth studies with PAO951-4 and PAO959, PAO1R4 grew extremely poorly when forced to use ornithine as the sole carbon and nitrogen source. The mutant isolate had a doubling time almost three times that of the wild-type strain PAO1 (Ͼ9 h versus 3.5 h). Remarkably, PAO1R4 was also completely unable to utilize ornithine as the sole carbon source in the presence of a more direct nitrogen source. This disability was a new and very distinctive phenotype for the PAO1R4 mutant. Such findings were intriguing since, in addition to the obvious deficiency in ornithine utilization, these results strongly implicated the involvement of some form of nitrogen control in ornithine utilization. Importantly, the growth of PAO1R4 on either arginine or proline appeared to be unaffected by the Gm r engineered recombinant. As a consequence of this seemingly specific effect upon ornithine utilization, the locus that had been inactivated in both PAO951-4 and PAO1R4 has been designated oruR.
Enzyme levels of SOAT, aOTCase and AST were also obtained for this specifically engineered mutant, but they were found to be statistically indistinguishable from those in the wild-type strain under all growth conditions tested (data not shown). Previously, Früh et al. (7) had demonstrated that oru (ornithine-utilizing) mutants that were unable to use ornithine as either a carbon or a nitrogen source (but had retained the ability to grow on arginine) were altered in either their anabolic or catabolic glutamate dehydrogenase activities (reactions 1 and 2 in Fig. 1 ). To test whether these enzyme activities had been modified, both enzymes were assayed in the wild-type strain and the PAO1R4 mutant, as were the catabolic OTCase   FIG. 4 . Comparison of the carboxy termini of OruR (amino acids 303 to 339) with the equivalent C-terminal regions of UreR from Proteus mirabilis and AraC from E. coli as examples of the AraC family of regulatory proteins. Lightly shaded residues denote sequence identity. Darkly shaded residues (white lettering) denote the rigorously conserved residues that constitute the AraC-like motif and define the consensus sequence for the family (6). a Units of enzyme activity are defined as micromoles of product per milligram of protein per hour, with standard deviations shown in parentheses. Experiments were undertaken in duplicate on a minimum of three independent isolates. b NG, no growth. PAO951 cannot grow in medium containing ornithine and citrate, although phenotypic revertants do appear at a rate approximating 2.5 ϫ 10
Ϫ4
. c -, Little growth was detected for either PAO959 or PAO951-4 isolates in medium supplemented with ornithine. Any growth is rapidly overrun by phenotypic revertants. Thus, no enzyme assays could be conducted on these strains under this particular growth condition.
(arcB; reaction 3 in Fig. 1 ) and the anaplerotic OAcT. With the notable exception of OAcT, none of these additional enzymes demonstrated any remarkably significant difference in their expression in the mutant strain from that in PAO1 (data not shown). The values for OAcT activity, however, indicate distinct differences in the activity of this enzyme under a number of pertinent growth conditions tested ( Table 3) .
Ability of OruR to bind to DNA lying directly upstream from its structural gene sequence. To verify that the observed amino acid sequence conservation of OruR with AraC and UreR was due to a potential DNA binding function of the protein, the intact oruR locus was cloned into pUCP18 (under the transcriptional control of the lac promoter; pMH4.8 [ Table 1 ; Fig.  2] ). The resulting gene product was then analyzed for its DNA binding activity. Partially purified protein extracts from E. coli (pMH4.8) demonstrated that OruR showed a specific ability to bind to a 176-bp fragment of DNA that lies directly upstream of the oruR structural gene, even in the presence of a greater than 50-fold excess of salmon sperm DNA (Fig. 5) . Similar binding patterns were achieved using protein extracts from PAO1 that had been grown in minimal media plus either arginine or ornithine (Fig. 5, lanes 6 and 7) . Bound DNA was noticeably absent, however, in the lanes corresponding to the cell extract from PAO1R4 that had been grown under similar conditions (lanes 8 and 9) . The specificity of OruR for this region of DNA was subsequently confirmed by its inability to interact specifically with other promoter sequences that were readily available in the laboratory, including the promoter regions of carAB from P. aeruginosa and catR,BCA from P. putida (data not shown).
DISCUSSION
Using a combination of transpositional mutagenesis and screening for the CIT r growth of mutant derivatives of PAO951, we were able to isolate a mutant strain of P. aeruginosa that could circumvent a block in the first step of proline biosynthesis (Fig. 1) . Along with its newly acquired ability to grow on ornithine and citrate, this mutant strain (PAO951-4) showed a significant decrease in its ability to utilize ornithine as the sole source of both nitrogen and carbon. The CIT r phenotype and associated enzyme activities of this transpositional mutant were strikingly similar to those of the original CIT r isolate (PAO959) of Voellmy and Leisinger, which they proposed might be an arginine regulatory mutant (40) . Fortified by the additional finding that levels of the catabolic AST were also uniformly repressed in both PAO951-4 and PAO959, these preliminary results (like those of Voellmy and Leisinger before us) led us to believe that the transpositionally inactivated locus (oruR) was directly responsible for the regulation of arginine metabolism. The homology of the deduced primary sequence of OruR to those of two members of the AraC family of regulatory proteins, in combination with DNA binding studies, confirmed the regulatory nature of the inactivated gene. Even so, subsequent characterization of a similar null mutation (this time constructed within the wild-type background of P. aeruginosa) suggested an additional level of regulatory complexity. The directed mutagenesis of the oruR locus in PAO1 resulted in the recombinant strain (PAO1R4), which was completely unable to use ornithine as a sole source of carbon. This finding confirmed the oru phenotype that we had previously inferred. However, any possibility that this oru phenotype resulted from the mutation of an arginine-specific regulatory locus was discounted by the fact that arginine utilization in this strain was notably unaffected under all conditions tested.
Despite the exaggerated deficiency in ornithine utilization of PAO1R4, the activities of all the enzymes that were known to be influenced by either ornithine or arginine (7, 8, 16, 40) failed to show any changes in PAO1R4 compared to their activities in the wild-type strain. Even enzymes that had previously demonstrated dramatic changes of activity in the original PAO951-4 isolate (aOTCase, SOAT, and AST) remained indifferent to the singular null mutation within PAO1R4 (aside from a slight but reproducible twofold increase in the activity of aOTCase in the presence of ornithine [data not shown]). Having exhausted all the more likely possibilities, we assayed the only other potential candidate within the arginine metabolic network, namely, OAcT (Fig. 1) . The activity of this enzyme did show some significant differences in the PAO1R4 mutant from that in PAO1 (Table 3) .
Even though OAcT has not previously been fully characterized in P. aeruginosa, its acetyltransferase activity is considered to perform a decidedly anaplerotic role in the recycling of the acetyl group used to acetylate glutamate in the first committed step of de novo arginine biosynthesis (4, 21, 29) (Fig. 1) . The results shown in Table 3 , however, demonstrate that OAcT expression is catabolite repressed by citrate. Moreover, expression of this enzyme is maximally enhanced by the presence of ornithine in the growth medium and considerably depressed by the presence of glutamate. Such findings support the possibility that OAcT from P. aeruginosa actually serves to generate glutamate from ornithine (at least under certain conditions), and does not merely recycle the acetyl group from acetylornithine, as had previously been assumed (4, 11, 37) . This catabolic activity would reverse the direction of the OAcT activity that is depicted in Fig. 1 and, in so doing, would potentially set up a futile cycle between glutamate and ornithine. While the for- FIG. 5 . Mobility shift assays of a 176-bp PCR DNA fragment of pMH4.1 that encompasses the region of DNA lying directly upstream of the oruR structural gene. Lanes: 1, 176-bp oruR po free DNA probe; 2, 0.066 g of E. coli DH5␣ (pMH4.8) (encoding the oruR structural gene); 3, 0.66 g of E. coli DH5␣ (pMH4.8); 4, 6.6 g of E. coli DH5␣(pMH4.8); 5, 6.6 g of E. coli DH5␣ (pMH4.9) (no oruR control); 6, 5 mg of PAO1 (grown in minimal medium plus arginine); 7, 5 mg of PAO1 (grown in minimal medium plus ornithine); 8, 5 mg of PAO1R4 (grown in minimal medium plus arginine); 9, 5 mg of PAO1R4 (grown in minimal medium plus ornithine). mation of such a cycle would be metabolically unsound, control of this cycle could play a key role in the regulation of de novo arginine biosynthesis from glutamate.
In P. aeruginosa, not one of the first five genes involved in converting glutamate to ornithine is negatively controlled by arginine (4, 11) (Fig. 1) . This is in marked contrast to the situation found in enteric bacteria and several species of Bacillus, where all the genes involved in arginine biosynthesis are negatively controlled by arginine through a central ArgR (AhrC) repressor protein (18, (22) (23) (24) 32) . Thus, a complete lack of negative transcriptional control by arginine within these initial steps of its own biosynthesis is quite unusual. If, as our results suggest, OAcT can be involved in the conversion of ornithine to glutamate, a tight, specific control of its expression would effectively regulate the net formation of ornithine from glutamate. The involvement of OruR in the expression of OAcT would indicate that such control could be brought about, at least in part, by OruR. It is this control that we contend is lost in PAO1R4.
OruR, however, is not the only means of controlling OAcT expression, as evidenced by the additional repressive effects of excess nitrogen and citrate upon its expression (Table 3 ). This diversity of control, together with the fact that the enzyme is not "essential" for arginine biosynthesis, supports our findings that a null mutation in OruR does not cause a complete arginine or ornithine auxotrophy. Even so, the inactivation of oruR does give rise to overtly sluggish growth on ornithine. It also disallows growth within a nitrogen-rich environment when ornithine is the sole source of carbon, conditions that would ordinarily severely repress the expression of OAcT.
What of the dramatic phenotypic differences between the two OruR mutant isolates, PAO951-4 and PAO1R4? While the reason for this is unclear, null mutations in argJ (OAcT) have previously been shown to be sufficient for the suppression of a similar (proB) mutation in proline biosynthesis within Streptomyces lividans (3). However, suppression of this proline block was apparent only in the presence of a marked excess of ornithine (3) . The results of our study indicate that the inactivation of OruR provides a similar suppression of proline auxotrophy in PAO951-4 by sufficiently altering the regulation of OAcT expression. It is therefore quite possible that a similar requirement for high levels of ornithine in this mutant selected for a secondary mutation, which resulted in the anomalous expression of SOAT, aOTCase, and AST.
The contrasting activities of AST and SOAT in PAO951-4 seem to be of some importance, since their respective genes appear to be transcriptionally linked within an operon cluster, aruCADB (14, 15) . Thus, the inordinately high levels of SOAT (aruC) in PAO951-4 ought to have been matched by similarly high levels of AST (aruA). Curiously, the expression of AST in PAO951-4 was extremely low under all conditions tested. Because the succinyl pathway is considered to be the major route for both arginine and ornithine degradation (7, 11, 36) , this uniformly low activity of the bifunctional AST would constrain the catabolism of both ornithine and arginine within the cell, tending to swell the pools of both metabolites. The increase in the level of arginine might then be sufficient to induce the expression of SOAT (OAT/ACOAT) by a more direct, arginine-specific regulatory mechanism (presumably through the recently discovered ArgR regulatory protein [27] ).
It is doubtful that the uniformly depressed levels of AST in PAO951-4 are a direct result of OruR inactivation, since the activity of AST showed no response to the singular mutation of OruR in PAO1R4 and the low levels of AST were not complemented by the transformation of PAO951-4 with a plasmid (pMH4.8) that encodes a functional oruR locus (data not shown). Moreover, similar discrepancies in AST and SOAT activities are also apparent in the PAO959 mutant isolate but not in the parental strain, PAO951. Collectively, these findings suggest that the loss of AST activity is probably due to a secondary mutation, resulting from the repeated selection for strong "citrate-resistant" growth of the oruR mutant within the proA mutant background.
While the complete metabolic role of OruR in ornithine metabolism is not yet fully understood, its definition (coupled to the activity of OAcT) suggests a heightened regulatory role for ornithine in an otherwise highly complex metabolic network that involves glutamate, arginine, and proline. In so doing, the identification of OruR addresses a number of concerns that have previously been raised by the isolation of a variety of oru phenotypic mutants (7, 25) . The ability of OruR to specifically bind to its own promoter-operator region (along with its similarity to AraC) clearly demonstrates its regulatory potential. Exactly how it exerts its effect upon other promoter sequences, such as potentially that of argJ, awaits their isolation and definition. In the absence of any apparent alteration in the expression of the more critical anabolic or catabolic enzymes within the arginine metabolic network, association of the inactivation of oruR with a complete loss of the ability of the cell to utilize ornithine as a carbon source makes its role in ornithine and arginine metabolism quite intriguing. Indeed, the potential for its proposed, rather oblique regulatory involvement in arginine and glutamate metabolism (through the circuitous control of ornithine recycling) is a somewhat unusual regulatory mechanism that certainly warrants further investigation.
